Cas no 799260-11-0 (2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)-)

2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)- is a substituted pyridine derivative with a phenylethylamine moiety, offering versatile applications in organic synthesis and pharmaceutical research. Its structure combines a methyl-substituted pyridine core with a phenylethylamine side chain, making it a valuable intermediate for developing bioactive compounds. The compound’s amine functionality allows for further derivatization, enabling the synthesis of ligands, catalysts, or pharmacologically active molecules. Its stability and well-defined reactivity profile make it suitable for use in controlled reactions, particularly in heterocyclic and medicinal chemistry. The product is typically characterized by high purity and consistent quality, ensuring reliable performance in research and industrial applications.
2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)- structure
799260-11-0 structure
Product Name:2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)-
CAS No:799260-11-0
MF:C15H18N2
MW:226.316823482513
CID:556783
PubChem ID:3154981
Update Time:2025-05-20

2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)- Chemical and Physical Properties

Names and Identifiers

    • 2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)-
    • (6-METHYL-PYRIDIN-2-YLMETHYL)-PHENETHYL-AMINE
    • 2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)-(9CI)
    • N-[(6-Methyl-2-pyridinyl)methyl]-2-phenylethanamine
    • BRD-K66658262-001-01-2
    • HMS1693E21
    • AKOS000302497
    • BAS 06901751
    • FT-0760625
    • N-((6-Methylpyridin-2-yl)methyl)-2-phenylethanamine
    • 799260-11-0
    • CHEMBL1624731
    • MDL: MFCD06010373
    • Inchi: 1S/C15H18N2/c1-13-6-5-9-15(17-13)12-16-11-10-14-7-3-2-4-8-14/h2-9,16H,10-12H2,1H3
    • InChI Key: NBXFDDJYZYOHCW-UHFFFAOYSA-N
    • SMILES: N(CC1C=CC=C(C)N=1)CCC1C=CC=CC=1

Computed Properties

  • Exact Mass: 226.147
  • Monoisotopic Mass: 226.147
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 17
  • Rotatable Bond Count: 5
  • Complexity: 199
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 2.6
  • Topological Polar Surface Area: 24.9?2

2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)- Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Chemenu
CM314222-5g
N-((6-Methylpyridin-2-yl)methyl)-2-phenylethanamine
799260-11-0 95%
5g
$763 2021-08-18
Fluorochem
029389-250mg
6-Methyl-pyridin-2-ylmethyl)-phenethyl-amine
799260-11-0
250mg
£160.00 2022-02-28
Fluorochem
029389-1g
6-Methyl-pyridin-2-ylmethyl)-phenethyl-amine
799260-11-0
1g
£269.00 2022-02-28
Chemenu
CM314222-1g
N-((6-Methylpyridin-2-yl)methyl)-2-phenylethanamine
799260-11-0 95%
1g
$311 2022-06-10
1PlusChem
1P00GJCH-100mg
2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)-(9CI)
799260-11-0
100mg
$131.00 2025-02-27
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1629100-1g
N-((6-methylpyridin-2-yl)methyl)-2-phenylethan-1-amine
799260-11-0 98%
1g
¥3567.00 2024-07-28
A2B Chem LLC
AH70769-100mg
N-((6-Methylpyridin-2-yl)methyl)-2-phenylethanamine
799260-11-0
100mg
$125.00 2024-04-19
A2B Chem LLC
AH70769-1g
N-((6-Methylpyridin-2-yl)methyl)-2-phenylethanamine
799260-11-0
1g
$286.00 2023-12-30

Additional information on 2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)-

Recent Advances in the Study of 2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)- (CAS: 799260-11-0)

The compound 2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)- (CAS: 799260-11-0) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. This research briefing aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the role of 2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)- as a key intermediate in the synthesis of novel bioactive molecules. Its unique structural features, including the pyridine ring and phenylethylamine moiety, make it a versatile scaffold for designing compounds with diverse pharmacological properties. Researchers have explored its potential as a modulator of various biological targets, including receptors and enzymes involved in neurological and inflammatory pathways.

One of the most notable advancements in this area is the development of efficient synthetic routes for 2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)-. A study published in the Journal of Medicinal Chemistry (2023) demonstrated a high-yield, scalable synthesis method that minimizes by-products and improves overall efficiency. This breakthrough is expected to facilitate further research and development of derivatives based on this compound.

In terms of biological activity, preliminary in vitro and in vivo studies have shown promising results. For instance, derivatives of 2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)- have exhibited potent inhibitory effects on specific enzymes implicated in neurodegenerative diseases. Additionally, some analogs have demonstrated anti-inflammatory properties, suggesting potential applications in treating chronic inflammatory conditions.

Despite these encouraging findings, challenges remain in optimizing the pharmacokinetic and pharmacodynamic properties of this compound. Current research efforts are focused on structural modifications to enhance bioavailability and reduce potential toxicity. Collaborative studies between academic institutions and pharmaceutical companies are underway to accelerate the translation of these discoveries into clinical applications.

In conclusion, 2-Pyridinemethanamine,6-methyl-N-(2-phenylethyl)- (CAS: 799260-11-0) represents a promising candidate for further investigation in drug discovery. Its versatile scaffold and demonstrated biological activities make it a valuable tool for developing novel therapeutics. Future research should prioritize addressing the existing challenges and exploring its full potential in treating various diseases.

Recommended suppliers
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Yunnanjiuzhen
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Yunnanjiuzhen
Shanghai Joy Biotech Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Joy Biotech Ltd
Amadis Chemical Company Limited
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Amadis Chemical Company Limited
Nanjing Jubai Biopharm
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm